Korean J Women Health Nurs.  2016 Sep;22(3):182-190. 10.4069/kjwhn.2016.22.3.182.

Impact of Cognitive Function and Cancer Coping on Quality of Life among Women with Post-chemotherapy Breast Cancer

• Kim YJ
• Kang SJ

• KMID: 2353892
• DOI: http://doi.org/10.4069/kjwhn.2016.22.3.182

Abstract

PURPOSE
This study was done to identify effects of cognitive function and cancer coping on quality of life among women with breast cancer treated with antineoplastic agents.
METHODS
The study was correlational research and participants were 145 women with breast cancer who had received antineoplastic agents. Data were collected from October to November, 2015 via online replies. Cognitive function was measured with the Functional Assessment of Cancer Therapy-Cognitive Function Version-3 (FACT-Cog), cancer coping, with the Korean Cancer Coping Questionnaire (K-CCQ), and quality of life with the Functional Assessment of Cancer Therapy-Breast Version-4 (FACT-B). Data were analyzed using descriptive statistics, t-test, ANOVA, Scheffé test, ANCOVA, Bonferroni test, partial correlation coefficient, and hierarchical multiple regression with SPSS 21.
RESULTS
Cognitive functions, total individual coping, and interpersonal coping explained 42% of quality of life. Cognitive function (β=.35, p<.001) was the best predictor of quality of life, followed by total individual coping (β=.34, p<.001), and interpersonal coping (β=.26, p<.001).
CONCLUSION
Results indicate that cognitive function and cancer coping are meaningful factors for quality of life among breast cancer survivors. Therefore when developing intervention programs for these women, content on cognitive function and coping skills as well as coping resources should be included.

Keyword

Cognition; Breast neoplasms; Antineoplastic agents; Quality of life

MeSH Terms

Adaptation, Psychological
Antineoplastic Agents
Breast Neoplasms*
Breast*
Cognition*
Female
Humans
Quality of Life*
Survivors
Antineoplastic Agents

Reference

1. National Cancer Information Center. Cancer incidence rate [Internet]. Goyang: National Cancer Information Center;2015. cited 2015 September 6. Available from: http://www.cancer.go.kr/mbs/cancer/subview.jsp?id=cancer_040101000000.

2. Park BW, Hwang SY. Depression and coping in breast cancer patients. J Breast Cancer. 2009; 12(3):199–209.

3. Deprez S, Amant F, Smeets A, Peeters R, Leemans A, Van Hecke W, et al. Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J Clin Oncol. 2012; 30(3):274–281.

4. Weiss B. Evaluation of multiple neurotoxic outcomes in cancer chemotherapy. Adv Exp Med Biol. 2010; 678:96–112.

5. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treat Rev. 2012; 38(7):926–934.

6. Jean-Pierre P, Winters PC, Ahles TA, Antoni M, Armstrong FD, Penedo F, et al. Prevalence of self-reported memory problems in adult cancer survivors: A national cross-sectional study. J Oncol Pract. 2012; 8(1):30–34.

7. Chae YR. Relationships of perceived health status, depression and quality of life of breast cancer survivors. J Korean Acad Adult Nurs. 2005; 17(1):119–127.

8. Fitch MI, Gray RE, Godel R, Labrecque M. Young women's experiences with breast cancer: An imperative for tailored information and support. Can Oncol Nurs J. 2008; 18(2):74–86.

9. Lee JH, Byun HS, Kim GD. Impacts of the mood state on the quality of life in breast cancer survivors. J Korea Contents Assoc. 2014; 14(7):356–366.

10. Kim GD. Impact of climacteric symptoms and fatigue on the quality of life in breast cancer survivors: The mediating effect of cognitive dysfunction. Asian Oncol Nurs. 2014; 14(2):58–65.

11. Chung BY, Cho EJ. Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncol Nurs. 2012; 12(3):221–229.

12. Wagner LI, Butt Z, Sweet JJ, Cella D. Measuring patient self-reported cognitive function: Development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol. 2009; 7(6):W32–W39.

13. Park JH, Bae SH, Jung YS, Jung YM. The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer. Support Care Cancer. 2015; 23(9):2695–2703.

14. Moorey S, Frampton M, Greer S. The cancer coping questionnaire: A self-rating scale for measuring the impact of adjuvant psychological therapy on coping behaviour. Psychooncology. 2003; 12(4):331–344.

15. Kim JN, Kwon JH, Kim SY, Yu BH, Hur JW, Kim BS, et al. Validation of Korean-cancer coping questionnaire (K-CCQ). Korean J Health Psychol. 2004; 9(2):395–414.

16. Greer S, Moorey S, Watson M. Patients' adjustment to cancer: The Mental Adjustment to Cancer (MAC) scale vs clinical ratings. J Psychosom Res. 1989; 33(3):373–377.

17. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, et al. Reliability and validity of the functional assessment of cancer therapy-breast quality-of-life instrument. J Clin Oncol. 1997; 15(3):974–986.

18. Yoo HJ, Ahn SH, Eremenco S, Kim H, Kim WK, Kim SB, et al. Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4. Qual Life Res. 2005; 14(6):1627–1632.

19. Ha EH, Lee SH, Jeong J, Lee HD, Lee JE, Nam SJ, et al. Biopsychosocial predictors of the quality of life in breast cancer patients. J Breast Cancer. 2010; 13(2):219–226.

20. Kim GD, Kim KH. Symptom cluster and quality of life in patients with breast cancer undergoing chemotherapy. Korean J Adult Nurs. 2011; 23(5):434–445.

21. Hedayati E, Alinaghizadeh H, Schedin A, Nyman H, Albertsson M. Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur J Oncol Nurs. 2012; 16(3):315–322.

22. Janelsins MC, Kohli S, Mohile SG, Usuki K, Ahles TA, Morrow GR. An update on cancer- and chemotherapy-related cognitive dysfunction: Current status. Semin Oncol. 2011; 38(3):431–438.

23. Lee JH, Lee HK. The mediating role of meaning in life in the relationship between religious coping styles and posttraumatic growth among christians. Korean J Relig Educ. 2011; 36:171–192.

24. Munir F, Burrows J, Yarker J, Kalawsky K, Bains M. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: A focus group study. J Clin Nurs. 2010; 19(9-10):1362–1370.

25. Silva SM, Crespo C, Canavarro MC. Pathways for psychological adjustment in breast cancer: A longitudinal study on coping strategies and posttraumatic growth. Psychol Health. 2012; 27(11):1323–1341.

26. Drageset S, Lindstrøm TC, Underlid K. Coping with breast cancer: Between diagnosis and surgery. J Adv Nurs. 2010; 66(1):149–158.

27. Biegler KA, Chaoul MA, Cohen L. Cancer, cognitive impairment, and meditation. Acta Oncol. 2009; 48(1):18–26.

28. Kang G, Oh S. Effects of mindfulness meditation program on perceived stress, ways of coping, and stress response in breast cancer patients. J Korean Acad Nurs. 2012; 42(2):161–170.

29. Park JH, Bae SH. A meta-analysis of chemotherapy related cognitive impairment in patients with breast cancer. J Korean Acad Nurs. 2012; 42(5):644–658.